New Light-Based imaging could speed up lung cancer diagnosis

NCT ID NCT05171478

Recruiting now Diagnosis Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new imaging technique called full-field optical coherence tomography (FFOCT) to examine small lung biopsy samples taken during bronchoscopy. Researchers want to see if FFOCT can provide results that match standard lab analysis, potentially allowing faster diagnosis of lung cancer and sarcoidosis. The study will enroll 20 adults already scheduled for a bronchoscopy as part of their routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Full-field optical coherence tomography (FFOCT) imaging
What this could lead to: If successful, FFOCT could provide faster, more accurate on-the-spot analysis of lung biopsies, potentially reducing wait times for diagnosis.
What could go wrong: This is a small early study with only 20 participants, and it is testing a new imaging tool against standard methods. It may not prove reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER SARCOIDOSIS

Contacts and locations

Locations

Johns Hopkins Hospital
RECRUITING

Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.